Cosmo Technologies Company Profile
✉ Email this page to a colleague
What is the competitive landscape for COSMO TECHNOLOGIES, and when can generic versions of COSMO TECHNOLOGIES drugs launch?
COSMO TECHNOLOGIES has one approved drug.
There are four US patents protecting COSMO TECHNOLOGIES drugs.
There are twenty-four patent family members on COSMO TECHNOLOGIES drugs in twenty-one countries and three supplementary protection certificates in three countries.
Summary for Cosmo Technologies
| International Patents: | 24 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Cosmo Technologies: | See patent lawsuits for Cosmo Technologies |
| PTAB Cases with Cosmo Technologies as patent owner: | See PTAB cases with Cosmo Technologies as patent owner |
Drugs and US Patents for Cosmo Technologies
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosmo Technologies | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | 8,741,948 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Cosmo Technologies | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Cosmo Technologies | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | 8,486,446 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Cosmo Technologies | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | 8,529,945 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cosmo Technologies Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1108196 | ⤷ Subscribe |
| European Patent Office | 1763339 | ⤷ Subscribe |
| Spain | 2303255 | ⤷ Subscribe |
| Japan | 5026262 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cosmo Technologies Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1763339 | 122019000048 | Germany | ⤷ Subscribe | PRODUCT NAME: RIFAMYCIN SV; NAT. REGISTRATION NO/DATE: 2200986.00.00 20190509; FIRST REGISTRATION: GB PL 08637/0028 20181218 |
| 1763339 | C201930053 | Spain | ⤷ Subscribe | PRODUCT NAME: RIFAMICINA SV; NATIONAL AUTHORISATION NUMBER: 84120-DE/H/5379/001/DC; DATE OF AUTHORISATION: 20190628; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): PL 08637/0028; DATE OF FIRST AUTHORISATION IN EEA: 20181218 |
| 1763339 | SPC/GB19/037 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: RIFAMYCIN SV; REGISTERED: UK PL08637/0028 20181218 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
